UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-07626 Sensient Technologies Corporation (Exact name of registrant as specified in its charter) Wisconsin 39-0561070 (State or oth ...

Sensient Technologies Corp (NYSE:SXT) Q2 2023 Earnings Conference Call July 21, 2023 9:30 AM ET Corporate Participants Stephen Rolfs - Senior Vice President and Chief Financial Officer Paul Manning - Chairman, Chief Executive Officer and President Conference Call Participants Ghansham Panjabi - Baird David Green - Boldhaven Operator Good morning and welcome to the Sensient Technologies Corporation 2023 Second Quarter Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-07626 Sensient Technologies Corporation (Exact name of registrant as specified in its charter) Wisconsin 39-0561070 (State or ot ...

Financial Data and Key Metrics Changes - Sensient's revenue for Q1 2023 was $369 million, up from $355.5 million in Q1 2022, representing a 5% increase in local currency [44][138] - Operating income decreased to $50.8 million from $52.8 million year-over-year [44] - Diluted earnings per share (EPS) were $0.80, down from $0.88 in the previous year, with foreign currency translation reducing EPS by approximately $0.02 [46] - Interest expense increased to $6 million from $3 million year-over-year [45] - The company's consolidated tax rate was 24.9% compared to 25.6% in the prior year [45] Business Line Data and Key Metrics Changes - The Color Group achieved 10% local currency revenue growth and over 6% local currency operating profit growth, driven by low-double-digit price increases [29] - The Food and Pharmaceutical product line saw a 16% local currency revenue growth, attributed to a high level of new sales wins [30] - Personal Care product lines experienced low-single-digit revenue decline due to customer destocking, particularly in North America [31] - The Flavors and Extracts Group's revenue decreased by approximately 1% in local currency, impacted by customer destocking and market downturns [32] Market Data and Key Metrics Changes - The Asia-Pacific Group delivered 15% local currency revenue growth and 18% local currency operating profit growth, not experiencing the destocking issues faced by other groups [139] - Destocking was most pronounced in the U.S. market, followed by Latin America, with Europe experiencing less impact [57] Company Strategy and Development Direction - The company is focused on internal investments and plans to prioritize capital allocation towards growth projects and potential bolt-on M&A opportunities [121] - Sensient aims to leverage its strong sales execution, customer service, and broad product portfolio to drive growth [43] - The company anticipates a recovery in the Flavors and Extracts Group, expecting mid-single-digit revenue growth for the year [41] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the opportunities in natural colors and the Personal Care portfolio's shift towards natural ingredients [4] - The company expects destocking to moderate in the second half of the year, leading to incremental revenue improvement [26] - Management noted that inflation remains a challenge, but pricing actions are being implemented to mitigate its impact [39][96] Other Important Information - Capital expenditures for Q1 2023 were $22 million, with expectations of around $95 million for the year [47] - The net debt-to-credit adjusted EBITDA ratio is currently 2.7, indicating a well-positioned balance sheet for capital expenditures and debt reduction [47] Q&A Session Summary Question: Can you elaborate on the destocking dynamics in the Food and Pharmaceutical segment? - Management indicated that the Food and Pharmaceutical segment effectively managed pricing and overcame destocking challenges, resulting in strong performance [65] Question: What visibility do you have on the inventory levels at customer and retailer levels? - Management noted that inventory is primarily at the customer level, with retailers not showing significant excess stock [75][92] Question: How do you view the impact of potential legislation on synthetic versus natural colors? - Management acknowledged the potential for increased conversion to natural colors due to legislative changes, which could be financially beneficial for the company [81][98]

SENSIENT® This document contains statements that may constitute "forward-looking statements" within the meaning of Federal securities laws including under "2023 Financial Outlook" in this presentation. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors concerning the Company's operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forwa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-07626 Sensient Technologies Corporation WISCONSIN 39-0561070 (State of Incorporation) (IRS Employer Identification Number) 777 EAST WISCONSIN AVENUE MILWAUKEE, WISCONSIN 53202-53 ...

Sensient Technologies Corp (NYSE:SXT) Q4 2022 Earnings Conference Call February 10, 2023 9:30 AM ET Company Participants Stephen Rolfs - SVP & CFO Paul Manning - Chairman, CEO & President Conference Call Participants Ghansham Panjabi - Robert W. Baird & Co. Heidi Vesterinen - BNP Paribas Exane Mitra Ramgopal - Sidoti & Company David Green - Boldhaven Operator Good morning and welcome to the Sensient Technologies Corporation 2022 Fourth Quarter and Year-End Earnings Conference Call. [Operator Instructions]. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 For the transition period from to Commission file number: 001-07626 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Sensient Technologies Corporation (Exact name of registrant as specified in its charter) Wisconsin 39-0561070 (State o ...

Sensient Technologies Corporation (NYSE:SXT) Q3, 2022, Earnings Call October 21, 2022 6:00 AM ET Company Participants Stephen Rolfs - Senior Vice President and Chief Financial Officer Paul Manning - Chairman of the Board, President and Chief Executive Officer Conference Call Participants Ghansham Panjabi - Robert W. Baird Heidi Vesterinen - Exane BNP Paribas Mitra Ramgopal - Sidoti David Green - Boldhaven Operator Good morning and welcome to the Sensient Technologies Corporation 2022 Third Quarter Earnings ...

SENSIENT® Third Quarter 2022 Investor Presentation FORWARD-LOOKING STATEMENTS This document contains statements that may constitute "forward-looking statements" within the meaning of Federal securities laws including under "2022 Financial Outlook" in this presentation. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors concerning the Company's operations and business environment. Important factors that could cause act ...